Dextrans clinical trials
How each study uses Dextrans is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
Cornea and Laser Eye Institute (1) · Ramathibodi Hospital (1) · Glaukos Corporation (1) · University of Virginia (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Dextrans is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic RiboflavinActive, not recruitingPhase 3Cornea and Laser Eye InstituteNCT01152541Written as Riboflavin/Dextran
- Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic AstigmatismTerminatedPhase 1/2Glaukos CorporationNCT01893359Written as riboflavin ophthalmic solution, 0% dextran
- Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney InjuryCompletedPhase 2/3Ramathibodi HospitalNCT03070353Written as Dextran 40
- Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial PeritonitisTerminatedPhase 4University of VirginiaNCT00570960Written as Dextran 70
Given beside what is tested · 1 — Dextrans is usual care or a partner of the new treatment
Codes
What other systems call Dextrans · ClinicalTrials.gg INT007324
- MeSH (NLM) D003911DextransConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7SA290YK68DEXTRAN 70Confirmed FDA, NLM, Wikidata
- Wikidata Q423123dextranConfirmed FDA, NLM, Wikidata
- DrugBank DB09255One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003911 | Dextrans | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7SA290YK68 | DEXTRAN 70 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q423123 | dextran | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB09255 | — | One source Wikidata |
Also registered as dextran 40 (UNII K3R6ZDH4DU) and dextran 75 (UNII JY83SHX053 · RxNorm 3275).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.